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Abstract 
Background: Dynamic consent has been proposed as a process through which participants and patients can gain 
more control over how their data and samples, donated for biomedical research, are used, resulting in greater trust in 
researchers. It is also a way to respond to evolving data protection frameworks and new legislation. Others argue that 
the broad consent currently used in biobank research is ethically robust. Little empirical research with cohort study 
participants has been published. This research investigated the participants’ opinions of adding a dynamic consent 
interface to their existing study.
Methods: Adult participants in the Extended Cohort for E-health, Environment and DNA (EXCEED) longitudinal 
cohort study who are members of the EXCEED Public and Participant Engagement Group were recruited. Four focus 
groups were conducted and analysed for thematic content. Discussion topics were derived from a review of the cur-
rent literature on dynamic consent.
Results: Participants were in favour of many aspects of a dynamic consent interface, such as being able to update 
their information, add additional data to their records and choose withdrawal options. They were supportive pro-
vided it was simple to use and not intrusive. Participants expressed a markedly high level of trust in the study and its 
investigators and were unanimously happy with their current participation. No strong support was found for adding a 
dynamic consent interface to EXCEED.
Conclusions: Trust in the study researchers was the strongest theme found. Openness and good data security were 
needed to retain their trust. While happy to discuss dynamic consent, participants were satisfied with the current 
study arrangements. There were indications that changing the study might unnecessarily disturb their trust. This 
raised the question of whether there are contexts where dynamic consent is more appropriate than others. This 
study was limited by the small number of participants who were committed to the study and biased towards it. More 
research is needed to fully understand the potential impact of adding a dynamic consent interface to an existing 
cohort study.
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Background
The Extended Cohort for E-health, Environment and 
DNA (EXCEED) is led by the University of Leicester, in 
partnership with University Hospitals of Leicester NHS 
Trust and in collaboration with Leicestershire Part-
nership NHS Trust, local general practices and smok-
ing cessation services[1]. Its aim is to develop a greater 
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understanding of the genetic, environmental, and life-
style-related causes of health and disease. Participants 
are aged between 30 and 69  years and were recruited 
through general practices in Leicester City, Leicestershire 
and Rutland, UK. There are over 10,000 participants. Like 
many cohorts, they are mostly older and female. A small 
proportion of participants (5%) report Asian and Asian 
British ethnicity [1], and future recruitment will focus on 
increasing this percentage.
Like many longitudinal cohort studies, EXCEED is 
looking for ways to make best scientific use of this pre-
cious resource, while adhering to its stated mission and 
the consents given by its participants. With changes to 
the legal frameworks and legislation surrounding data 
protection (i.e. the European General Data Protection 
Regulation (GDPR)[2] and the UK Data Protection Act 
2018[3]), it is necessary to ensure that EXCEED contin-
ues to fall within agreed legal structures. Equally, as a 
consequence of the landmark judgement in Montgom-
ery v Lanarkshire Health Board, in 2015[4], discussions 
around consent are now changing, “…redefin[ing] the 
entire basis of the doctor-patient relationship in the eyes 
of the law…”[5]. It is no longer sufficient to provide infor-
mation based simply on what the medical professional 
believes they should provide. Disclosure must focus on 
what information the patient or participant wishes to 
receive to make an informed decision. This shift in think-
ing has also penetrated the research sphere. It has given 
EXCEED the opportunity to explore new approaches for 
involving participants in discussions regarding how they 
wish to interact with the study. One approach suggested 
was to design a dynamic consent interface.
Background
Dynamic Consent has two accepted meanings in the 
literature. First, it is, “…a new approach for engaging 
individuals about the use of their personal informa-
tion”[6]. This reflects the changing attitudes towards con-
sent, away from the traditional paternalistic model and 
towards a more patient/participant-centred model. It also 
reflects the continuing concern about ‘broad’ consent in 
biobanking[7, 8]. Under broad consent individuals can 
agree to the use of their samples and associated data for 
future unknown research projects, reassured that appro-
priate governance mechanisms, including ethics review, 
are in place. This has been used successfully by studies 
such as UK Biobank[9]. However, many have questioned 
whether a broad consent continues to be a truly informed 
consent[6, 10]. A recent study, “…suggest[s] that prefer-
ences collected during the initial consent process do not 
dependably predict long term opinions of biobank par-
ticipants”[11]. Researchers are now investigating techno-
logical approaches or ‘participant-centric initiatives’ [12] 
in biobanking to overcome perceived shortcomings in 
broad consent.
This leads to dynamic consent’s second meaning, “… a 
personalised communication interface to enable greater 
participant engagement in clinical and research activi-
ties” tailored to fit the research study[6]. Through an 
interface, researchers can provide information about 
current and proposed research activities to consented 
participants. Participants could see their consent pref-
erences in one place and modify them if they wish or 
withdraw from the study, at their own convenience. An 
interface could enable participants to state their prefer-
ences to be re-contacted to complete a questionnaire for 
an existing study, or to join new studies. There are sev-
eral perceived advantages. A dynamic consent interface 
could allow better communication between researchers 
and participants[6]. Public and participant trust could 
be improved through greater transparency and account-
ability[6, 13]. Using an interface could improve scientific 
literacy[6]. Interfaces can be changed to reflect changing 
legal requirements [13]. Because it is an online tool, it 
could be a way to improve inclusivity and remove barri-
ers [14]. It has been suggested that dynamic consent can 
improve trust and encourage engagement in less well 
represented communities, “…by promoting improved 
understanding of the biobank and its research outputs, 
and a stronger sense of collaboration between donors 
and researchers”[15].
Those more sceptical of patient-centric interfaces 
question the rush to discard broad consent[16]. Broad 
consent, in their view, also respects the autonomy of par-
ticipants[16]. Participants, by accepting broad consent, 
have shown that they are comfortable with others making 
decisions on their behalf regarding future use of data and 
samples. Being asked for their opinion may make some 
question their own competence to participate[16]. Asking 
for consent for every new study could make those new 
options appear trivial[16]. Patient-centric interfaces must 
be kept secure and up to date for an unknown length of 
time, which could have cost and staffing implications. 
Some groups, such as the elderly or disadvantaged, may 
not be willing or able to engage in a technology-based 
consent process. This could be due to a lack of desire or 
understanding, or access to infrastructure[17, 18].
The legal framework, which provides that researchers 
must obtain the informed consent of participants before 
they may be included in a study, does not preclude the 
giving of broad consent, and nor is it likely to do so at any 
time soon. This is true both of the GDPR (and it should 
be noted that at the time of writing that given Brexit there 
is no certainty about the future application in the UK of 
the GDPR), and indeed of the common law. That said, 
it is the latter that provides an interesting perspective. 
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The landmark case of Montgomery v Lanarkshire Health 
Board mentioned above directly connects the concept 
of informed consent with autonomy, and indeed the 
courts have been moving towards such an explicit link-
age for some time[19]. In this regard, the proponents of 
dynamic consent may well opine with some justification 
that dynamic consent interfaces are very much consistent 
with the view of the doctor-patient relationship imagined 
by the Supreme Court. Thus, “patients are now widely 
regarded as persons holding rights, rather than as the 
passive recipients of the care of the medical profession. 
They are also widely treated as consumers exercising 
choices”[4]. In this atmosphere, then, there will inevita-
bly be pressure to move away from broad consent, and 
towards a dynamic consent model. Montgomery, despite 
being a case about the doctor-patient relationship, is still 
highly relevant to the research context. This is because 
the Supreme Court’s judgment did not limit itself to 
the facts of the case. Rather, the judgment is deliber-
ately wide-ranging and concerns itself with medical law 
as a whole, cementing autonomy as central to any and 
all cases [5]. Moreover, it concentrated on the relation-
ship and balance of power between medical profession-
als and patients in a manner which, if anything, will be 
even more applicable in a researcher-participant inter-
action than it is in the doctor-patient relationship given 
the importance it placed on bodily integrity and the abil-
ity of patients/participants to exercise choice based on 
the information that they are entitled to. This is a view 
shared by McHale, who argues that the new standard of 
disclosure imposed by Montgomery will be “impossible 
to ignore” in the research context, particularly given the 
emphasis on autonomy and the fact that a research par-
ticipant is “an individual who is a participant in clinical 
research can be seen as acting fundamentally in the pub-
lic interest and for the public benefit”[20]. It should also 
be noted that not only was the decision more of an evolu-
tion than revolution, in that the courts had been moving 
in its direction for a while, but it was also consistent with 
the critiques of medical law that existed in the academic 
literature[5, 19].
Researchers have been exploring dynamic consent with 
different communities. Examples include rare disease 
communities[21, 22], in studies using electronic medi-
cal records[17, 23], and, like EXCEED, ‘healthy volun-
teer’ studies[24–27]. Details are limited on how healthy 
volunteer studies have implemented a dynamic con-
sent approach. A recent survey reported that five large-
scale research cohorts, at the time of writing, had set up 
interfaces to implement a dynamic consent approach. 
The authors see “dynamic-informed consent” as com-
prising dynamic permissions, dynamic education, and 
dynamic preferences[28]. Within each of these, there 
are specific actions such as the ability to select whether 
to receive individual research results as a dynamic pref-
erence[28]. Each of the five studies has implemented 
some of these activities. For example, the RUDY (Rare 
UK Diseases of Bone, Joints and Blood Vessels) study, 
has an on-line interface where participants self-report 
data about themselves and their condition, and actively 
choose the research for which their data and samples 
can be used[21, 22]. The Cooperative Health Research in 
South Tyrol (CHRIS) study is a population-based longi-
tudinal study “… [investigating] the genetic basis of com-
mon chronic conditions associated with human ageing, 
and their interaction with life-style and environmental 
factors in the general population of South Tyrol”[25]. 
Like EXCEED, the CHRIS study allows for the return of 
individual genetic findings. Its participants can choose, 
through their interface, whether to receive results. None 
of the five studies had implemented all of the elements 
for dynamic-informed consent. The only element all had 
included was the ability to withdraw[28]. This suggests 
that achieving full dynamic-informed consent is com-
plex and to be successful, a step-by-step approach was 
needed.
After discussions with the EXCEED Scientific Commit-
tee, the hypothesis was formed that participants would 
be enthusiastic about EXCEED adding a dynamic consent 
interface. However, any system would need be accepted 
by the EXCEED participants and engagement was needed 
to identify what components they would want included. 
It was also clear that there were enough questions around 
dynamic consent that our hypothesis would need to be 
confirmed through a research study as opposed to simply 
implementing a new system. Focus groups were chosen 
as they allowed us to explore the shared ideas and opin-
ions of the participants who would be using an interface. 
The following research questions were identified: a) what 
do our participants think about the concept of dynamic 
consent and b) what characteristics of a dynamic con-
sent interface did EXCEED participants believe should be 
a part of their interface? This paper presents the results 
of the focus groups and shows the critical importance of 
engaging with participants regarding any proposed sys-
tem changes.
Methods
Focus group participants were recruited from the 
EXCEED Public and Participant Engagement Group. The 
EXCEED cohort, which has consent for re-contact of par-
ticipants, sent out information on this study to its mem-
bers; those who were interested contacted JM directly to 
agree a date on which they could attend. JM had previ-
ously presented the concept of dynamic consent and the 
fact that the research was going to be conducted at an 
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earlier Public and Participant Group meeting. This was 
an impartial presentation to tell members that EXCEED 
was investigating this idea and wanted the input of those 
interested.
Both researchers have had prior experience in con-
ducting qualitative interviews and focus groups. SEW is 
a consultant academic researcher, who was previously 
Lecturer at the University of Leicester; She led the focus 
groups discussions. JM was, at the time of research, Pro-
fessor of Law at the University of Leicester and is now 
Professor of Law at the University of Leeds. He assisted 
with leading the discussions and took written notes.
All FGs were audiotaped with consent of the par-
ticipants. Audiotapes were transcribed and transcripts 
anonymised. The transcripts were not returned to par-
ticipants for checking. Thematic analysis was chosen to 
analyse the data. Both authors independently reviewed 
the written transcripts. SW created the initial codes 
from the data (no formal coding tree was prepared) and 
from these, suggested initial overarching themes. JM 
compared these to the themes he had identified inde-
pendently. Both authors conferred and then agreed the 
thematic descriptions. SW drafted the first selections 
of illustrative quotes. JM revised and added additional 
quotes. All audio tapes were destroyed after transcrip-
tion. The signed consent forms and transcriptions will 
be retained in a secure location for six years and then 
destroyed, in accordance with University of Leicester’s 
Information Handling Policy. The results were presented 
and discussed at an EXCEED Public and Participant 
Group meeting in November 2019.
Results
Four focus groups, with 3–6 men and women in each, 
were held at College Court, University of Leicester, in 
a private meeting room over two days in June 2019. 
Each session lasted approximately 1–1.5 h with a break, 
if desired, offered halfway through. Two participants 
did not attend on the day with no reason given, so one 
group only had one participant; this was conducted as an 
in-person semi-structured interview. Only the partici-
pants and the two researchers were present at each focus 
group. At the beginning of each session, participants 
were welcomed and told how the session would proceed. 
They were told that they could leave at any time if they 
wished without explanation. They were asked for their 
consent to have the session audiotaped. Consent forms 
were passed out and participants asked to complete 
them. Travel expenses were covered for participants to 
attend and forms for this were also distributed.
Focus group members were given an overview of the 
EXCEED Study and then of specific elements of dynamic 
consent. For each element, we sought to gauge their 
understanding of the concept, link this to related expe-
riences and explore their reactions and comfort levels 
(study interview guide available as a supplementary doc-
ument). The goal was to map out what a dynamic consent 
interface might look like for these EXCEED participants.
Overview discussion of the EXCEED Cohort Study 
and introduction to dynamic consent
Each focus group began with an overview of EXCEED 
to remind the participants of its aims and the details of 
the consent under which they had agree to participate. 
Dynamic consent, as a concept and as an interface, was 
also next introduced. They were introduced to the fact 
that a dynamic consent interface could help participants 
understand better what data EXCEED had about them. 
They could, for example, check to see if it was up to date 
and change it if needed. Participants were positive about 
this:
I never even thought – or probably didn’t even know 
how to get in touch with to tell you of my change 
of address, so something like that I think is quite, I 
would say is useful. [Female 1, Focus Group 2].
It also became clear that many of our participants 
had difficulty remembering what their participation in 
EXCEED involved. They thought that having a homepage 
describing EXCEED, its aims and its progress would be a 
good thing to remind them to what they had consented. 
This showed that participation in a study can be put to 
the back of one’s mind:
[I]f you ask me quite what I agreed to I probably 
couldn’t tell you at the moment. …[A] brief bit of 
what EXCEED is and…what the agreed research 
purposes initially were… a reminder would be quite 
useful. [Female 1, Focus Group 2].
It was during this initial discussion that the issue of the 
security of data within EXCEED was raised by the par-
ticipants. Indeed, in two of the groups it was the very 
first thing mentioned, showing that it held paramount 
importance to our participants. As they have provided 
their personal data to EXCEED, including their genetic 
profile, keeping those data secure was a key requirement 
for them. There may have been some confusion as some 
participants appeared to believe that a dynamic consent 
interface would link directly to their EXCEED data. Even 
with the reassurance that this would not be the case, 
participants reiterated their view that a secure system 
was vital for retaining their trust in EXCEED and their 
participation:
And the most important part of it would be the secu-
rity, the encryption….I go to lots of different things in 
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the NHS, the people I talk to, they’re scared of that 
that information is going to get out….I’ve said ‘why 
don’t you do the research’, ‘oh I’m not giving them my 
details.’ [Male 1, Focus Group 1].
[A]nything I give you that’s going to go on the inter-
net is not 100% safe…so the next stage is what real-
istically will be in place to protect any that that’s 
going to be accessible in that way, and do I think 
what you’re taking from me matters so much that if 
it did get breached, how upset would I be about it… 
[Female 1, Focus Group 2].
Ability to provide additional information about oneself 
and see how data was being used
Participants next discussed whether they would like to 
be able state their preferences around adding new data, 
for example through online questionnaires. This could 
include saying ‘yes’ or ‘no’ to being asked about or agree-
ing to some approaches from outside sources. Many said 
that they completed questionnaires for other studies and 
would be happy to do this for EXCEED, although they 
preferred it if the questionnaires were easy and fast to 
complete:
Yeah, I think it would be quite easy for you to set it 
up anyway. And then of course collecting the data is 
going to be a lot easier for you because it’s going to be 
the computer and not only that, as long as you say 
it’s yes/no or there’s three choices. If you start getting 
where people have to type things out – … [Male 1, 
Focus Group 1].
Very much so, if it’s multi choice answers, not as…
over there said, your life story” [Male 4, Focus Group 
1].
But as this participant went on to say, they also wanted 
know results from the research to which they were 
contributing:
I’m fed up with sending questionnaires and not 
knowing what’s going on when it’s finished. [Male 1, 
Focus Group 1].
It was clear that the participants were eager to have 
whatever results from research that might help improve 
their or their family’s’ health or well-being, as was shown 
in this exchange:
[Male 2, Focus Group 3] “I would be open in wanting 
to know everything –
[Female 2, Focus Group 3] So would I.
[Male 2, Focus Group 3] About myself, because if 
you can do something that’s going to stop, or make 
something slightly easier, not quite so harsh, I don’t 
know…, but if there’s something that could ease or 
help, then yes, I’d want to know.”
Participants also wanted to be able to ignore an inter-
face if they wished. They welcomed the thought that they 
could take a vacation from it, notifying EXCEED if they 
were to be out of touch for a length of time, but would be 
happy to be contacted again on their return:
[S]ome people wouldn’t want to be contacted at all, 
or might say that this is getting too much and would 
say ‘I’d like to opt out for a while’,…and then could 
change …when they felt they did want to join in 
again. [Female 2, Focus Group 1].
But they would not welcome a complicated system or 
one that required significant attention:
…I’m a bit worried…are you getting too complicated. 
…Have a safe, well put together IT system and keep 
the questions simple and relevant. And then we’ll 
carry on being part of the study. [Female 1, Focus 
Group 2].
How will we know that there’s a question on this site, 
presumably they’ll email us won’t they, to say you 
need to go on to your site. We’re not expected to go 
on it every day to see if anything’s… [Male 1, Focus 
Group2].
Opinions differed regarding how often would be bur-
densome, with the general feeling being:
[p]robably no more than two or three times a year, 
I don’t know. Something like that [Female 2, Focus 
Group 2].
Ability to withdraw completely or for a period
This desire for a system that was easy to use also applied 
to being able to withdraw. They felt it would be helpful 
to do this through the interface and to be able to choose 
levels of withdrawal (e.g., complete destruction of all 
samples and no further use of data, no further contact 
but use of their samples and data, etc.) But the interface 
could also give them a chance to reconsider their with-
drawal decision:
You could have gone through a really bad period of 
things, you know,…’there’s no point in this, I’m out.’ 
And then a few days later you think again. So, I 
would think definitely a time lapse period. [Male 2, 
Focus Group 3].
Ability to be recruited to other studies
The participants considered how they wished to be 
recruited to other research studies. There were differing 
views as to who could contact them for what research 
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purpose. Some people did not mind being approached by 
a broad range of researchers for differing projects. They 
recognised that this sharing of data for other research 
purposes was key:
[B]ecause you don’t know what people want to 
study…there’s all sorts of different studies going on…
and you don’t know whether you can help until 
you’re asked. [Female 2, Focus Group 3].
There was an almost universal desire that requests 
come through EXCEED rather than from outside 
researchers. They had confidence that EXCEED would 
have vetted those making the request. This was made 
plain by one participant, who made the point in explicit 
terms:
I don’t really know whether this drugs company is 
benign, a nice company, and this drugs company’s 
horrible, I’ve no way of knowing. But what I would 
hope is that you would make some judgements about 
who you wanted to be involved with or who – you 
know. So again, it comes back to this trust business, 
doesn’t it…? If I’m involved with the EXCEED study, 
I’m happy to be involved with it until I lose faith 
with the EXCEED study or Leicester University or 
whatever. [Male 1, Focus Group 2, emphasis added].
Ability to receive information about yourself
EXCEED participants had already stated their willingness 
to be notified of incidental findings as part of the origi-
nal EXCEED consent. They were happy for the interface 
to give them the choice of whether they wanted results 
or not. Participants were clear, however, that if someone 
wanted to contact them with important news, it should 
be delivered personally and not through the interface or 
by letter:
[S]urely you wouldn’t then just send me something 
that says ‘well actually you’ve got this’, ‘you’re show-
ing that you’re going to get dementia in the next 
five years’, … surely it would be better to say a gen-
eral ‘do you want to know, yes or no’, on the under-
standing that if you do find anything you’re not just 
going to get a bald letter or whatever…. It’s going [to 
be] ‘someone is going to contact you and talk you 
through it’. [Female 1, Focus Group 2].
Dynamic consent and possible marginalisation
Unprompted, the question of whether dynamic consent 
might be a disadvantage to some was raised. Two of our 
participants in different focus groups stated that they 
either did not use the internet regularly or did not own a 
computer. This prompted one participant to ask:
[H]ow are you going to deal with people who say ‘I 
don’t use the internet’ and everything else, … not 
everyone’s computer literate, so if you go down this 
route how are you still going to make sure that you 
don’t exclude people… [Female 1, Focus Group 2].
The possibility of being marginalised also was raised 
by another participant who noted the low representa-
tion of those from the British Asian communities in the 
EXCEED cohort.
Security, trust and loyalty
The strongest theme found across the focus groups was 
that participants trust the EXCEED investigators and the 
affiliated institutions. They are happy that they joined the 
study and, providing the current level of security for their 
data is maintained, remain content with things as things 
are. They did understand why we were exploring adding 
an interface:
[Y]ou are now faced with this problem of…data pro-
tection… And so obviously you have a lot of thinking 
to do … and one of the solutions … is to ask us lots of 
question about what we want to happen. But I think 
in a way we’ve given you our consent, you know? … 
[I]t up to you to do the hard thinking and to come 
up with the solution here. … And we’re quite happy 
… to say we’ve given you our consent, this is the cri-
teria which we’ve given you our consent under, don’t 
bother us with lots and lots of questions … [Male 1, 
Focus Group 2].
Two facets to trust were evident: there was a very high 
level of trust in EXCEED, and a confidence that EXCEED 
would not provide inappropriate access to their data:
…I would be happy to have something that pinged to 
me and said ‘go and have a read’…if I have a request 
from [City] or wherever,…that they are looking to do 
this, …are you happy for them to see your data, …
and see if it’s something that…I would like to take 
part in. I would have to trust that you had checked 
that they were ethical and meeting all the things that 
– before you even requested it…and I have no reason 
to believe you wouldn’t be doing that. So, then I can 
look at it and just think…get on with it. Or, I don’t 
fancy that one. [Female 1, Focus Group 2].
The participants acknowledged that they had to trust 
EXCEED to judge the scientific quality and ethical 
robustness of requests for the use of participant data
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Meanwhile, there was a lack of trust in an interface if it 
was linked to their personal data and was not perceived 
as secure:
Giving you the data,, giving you our name and 
address and all…how do I know how secure it is at 
your end? How are you going to convince me that 
it is secure, because we hear of breaches every day. 
[Male 1, Focus Group 2].
Thus, in relation to security, the trust and loyalty dis-
played by participants towards EXCEED was evident. 
They were happy for EXCEED to use their information 
as agreed (and were thus content with the broad consent 
that they had provided) as a direct consequence of that 
confidence. But it was also made clear that this confi-
dence could be eroded:
I only have two concerns really, one is that I can 
trust the people who are doing it, that’s my first con-
cern. But my second concern is that all these things 
happen at the moment within a sort of fairly benign 
sort of social and political sort of culture. And it 
seems to me that in some ways you can feel that is 
changing, so what’s it going to be like five years’ time 
or ten years’ time, you know, what – it’s how things 
might change. At the moment I feel that I can trust 
people, you know, and I don’t really care, do what 
you like, at the moment. I just have slight misgivings 
that in the future things might be different and uni-
versities might come under different sorts of political 
and social pressure, you know, and that’s already I 
understand, starting to happen a little bit in [coun-
try], and I’m just uneasy about it. [Male 1, Focus 
Group 2].
Furthermore, this trust was linked to the altruism that 
motivated them to join the project in the first place:
When I had a stroke, I got the thing in my head that 
I wanted to help as many people as I can, because 
I would hate anybody to have to go through what I 
went through. And anything I can do to help any-
body in the future will, and – I will give my full con-
sent to. I’ve got the same sort of opinions. [Male 2, 
Focus Group 3].
Payback time. [Male 1, Focus Group 3].
Discussion
In general, our participants thought that a dynamic con-
sent interface would be a good addition to EXCEED. 
They agreed with many points that had been found in the 
literature. They felt it would help them to interact with 
the study and its personnel. They could update address 
information or how often they might be contacted to add 
more data. They could state their preferences regard-
ing whether to receive individual research results. They 
would welcome information on how their data was lead-
ing to new research advances. On the other side, our 
participants did raise points that reflect some concerns 
about dynamic consent. Some of our participants did 
not use computers or smartphones, although they did 
suggest other ways that they might be able to access the 
interface (i.e., through relatives or by using a shared com-
puter at a library.) Any interface needed to be easy to use 
and something they could ignore if they wanted. Some 
aspects of dynamic consent did not arise, such as the sug-
gestion that dynamic consent could improve scientific 
literacy or empower participants [6]. Similarly, there was 
no comments that dynamic consent might provoke feel-
ings of scientific inadequacy.
One oft-mentioned aspect of dynamic consent is that it 
can show respect to participants and improve their trust 
in a research study[12]. Based on our focus groups, our 
participants have high levels of trust in EXCEED and are 
content with their current status. They appeared proud 
of their contribution and feel a part of EXCEED. They 
were happy if the researchers wanted to pursue an inter-
face, but they did not give any strong indications that it 
was needed. If anything, the addition might appear to 
introduce risk, and might jeopardise their relationship 
with the study. Contrary to the literature, we believe 
that the introduction of a dynamic consent interface at 
this stage would not improve participants’ relationship 
with EXCEED but could introduce a risk of causing a 
deterioration in trust if something went wrong. In fact, 
it became apparent that this key issue pervaded all the 
themes that we have identified. The risks associated with 
an erosion of trust in EXCEED outweighed any antici-
pated benefits.
Ethically, there is much to be said for the introduction 
of dynamic consent interfaces. Unless we espouse a form 
of libertarianism where research participants ‘sell’ their 
data or consent as a single process, the broad and blan-
ket consent can only be seen to be suboptimal accord-
ing to the reasoning behind dynamic consent models. 
This becomes even more the case the greater distance 
between the consent given for the original project and 
any data access requests, given that participants often 
do not remember to what they originally consented[29]. 
Indeed if, as the Supreme Court noted, “the courts have 
become increasingly conscious of the extent to which 
the common law reflects fundamental values”[4], then 
the development of dynamic consent can only be con-
sidered to be a positive development. A future court 
could, although we think it unlikely in the near future, 
ask why one was not incorporated into a research study 
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if a participant were to complain after the fact that their 
information was used in a way not envisaged when they 
provided broad consent. After all, the Supreme Court in 
Montgomery also held that the uncertainty for medical 
professionals caused by a patient-centred legal frame-
work (albeit in relation to physical harm) could be justi-
fied if the aim were to protect the interests of patients: “a 
degree of unpredictability can be tolerated as the conse-
quence of protecting patients from exposure to risks of 
injury which they would otherwise have chosen to avoid. 
The more fundamental response to such points, how-
ever, is that respect for the dignity of patients requires no 
less”[4].
Our findings suggest that there could be potential 
advantages to using a dynamic consent interface for cer-
tain groups, but not for others. For instance, patient and 
rare disease communities appeared especially enthusias-
tic. Therefore, one potential avenue for future research 
would be to investigate whether there are contextual dif-
ferences that might make some studies appropriate for an 
interface but not others. For example, could the makeup 
of the cohort and its stage of development be key factors 
in deciding whether to have a dynamic consent inter-
face? It may be found that using the interface with single-
site studies from the beginning might increase success. 
Attempting to retrofit a healthy volunteer study that has 
been progressing safely and with positive results, such 
as the EXCEED study, may not be a useful exercise. But 
more empirical evidence in all these settings is needed.
We also feel that the study highlights the need for 
some more legal research in this area. Within the focus 
groups, as noted above, we found a range of views about 
a dynamic consent interface, but almost universal satis-
faction with the broad consent that had been provided, 
a function of the trust in EXCEED. Of course, cases 
only come to court when that trust has been eroded or 
broken, and the question becomes how the law might 
respond where broad consent was provided but the rela-
tionship changed. This includes the question of how it 
ought to respond, particularly when some participants 
will have been happy with whatever happened to break 
the bond between researchers and some participants. 
These are complex issues of policy as well as detail and, as 
we suggested earlier, they are exacerbated by the courts’ 
current view that some uncertainty on the part of medi-
cal professionals may be warranted in return for greater 
protection of the dignity of patients. One solution might 
be to insist on a dynamic consent framework so that 
researchers could protect themselves legally. Given what 
we have found above this might seem almost like impos-
ing the model against the wishes of participants. A more 
detailed legal analysis than there is room for in this paper 
needs to be conducted.
Limitations
This study has several limitations. It was quite small, and 
participants were self-selected. Additional focus groups 
would be needed to ensure representation of views across 
the cohort. As members of the EXCEED Public and Par-
ticipant Engagement Group, they are committed to the 
study. However, because they are interested in outreach 
processes, it was felt they were an appropriate group to 
recruit. While some participants were introduced to the 
concept of dynamic consent and the fact that EXCEED 
were exploring adding an interface, we do not feel that 
this biased their views ahead of the focus groups. There 
are a small but significant number of EXCEED members 
from the minority South Asian community. One member 
did participate but a greater number would have been 
needed to draw any conclusions as to whether dynamic 
consent might be more or less welcomed by this commu-
nity. An additional independent researcher would have 
been useful when analysing the data to confirm the codes 
chosen, suggest themes that might have been missed and 
provide added impartiality to the analysis process.
Conclusions
Dynamic consent has been mooted as having, “…the 
potential to radically change the nature of participation 
in both clinical care and research”[6]. Success has been 
shown when used in the rare disease and other patient 
communities. There is more limited evidence for its 
effectiveness in healthy volunteer biobanks. While it 
is argued that dynamic consent interfaces can be ben-
eficial for improving engagement with minority popula-
tions[15], more evidence is needed.
We found our hypothesis disproven. While in general 
positive about the concepts around dynamic consent, 
our participants did not appear eager to have a dynamic 
consent interface as part of the existing EXCEED study. 
While they were ready to give suggestions as to the 
characteristics they felt should be a part of the inter-
face, they did not strongly advocate for one. Our find-
ings also raise the question of whether the addition of an 
interface might introduce more risk to the trust held by 
the participants than provide benefits. Our participants 
were content with the broad consent that they had given, 
in large part due to the trust that they had in EXCEED. 
Additional research is needed to further explore whether 
dynamic consent is needed by all, or whether there are 
specific contexts where it would be most welcomed.
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